Valeant Pharmaceuticals International Inc said it agreed to purchase privately owned eye drug firm Eyetech Inc, to expand its ophthalmology business. Financial details of the deal were not disclosed, but Valeant said it would include an upfront payment and potential future milestones.The deal is expected to be "immediately accretive," Valeant said in a statement.In February, Valeant bought Brazil's Probiotica Laboratorios Ltd for about $86 million, boosting the Canadian company's presence in the sports food supplement market.In January, Valeant withdrew its sweetened takeover bid for Ista Pharmaceuticals Inc, citing a lack of progress in talks.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX remained unchanged at $48.11. In the past year, the shares have traded as low as $33.91 and as high as $54.28. On average, 615354 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 0.
ISTA Pharmaceuticals, Inc. (ISTA) is a commercial-stage, multi-specialty pharmaceutical company. Shares of ISTA remained unchanged at $8.12. In the past year, the shares have traded as low as $2.88 and as high as $11.39. On average, 442835 shares of ISTA exchange hands on a given day and today's volume is recorded at 0.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX remained unchanged at $47.91. In the past year, the shares have traded as low as $32.05 and as high as $57.24. On average, 1832670 shares of VRX exchange hands on a given day and today's volume is recorded at 0.
Source
